Rinat Sergeev Drug-Resistant Tuberculosis Modeling the Dynamic Relationship Between HIV and the Risk of

that longitudinal studies, not a snapshot, will provide a better picture of the whole evolving story. . suggest et al perhaps as a result of less stringent selective pressure. Thus, Sergeev −− HIV-seronegative populations drug-resistant TB in HIV-seropositive populations may actually be less fit than drug-resistant TB that develops in rare. Intriguingly, although HIV infection may increase the prevalence of drug-resistant TB within a population, infections, acquired at a time when drug-resistant TB was M. Tb explained by HIV-stimulated reactivation of latent developing drug-resistant TB at the early stages of the coepidemic. Although counterintuitive, these results may be infections within a community over several decades, HIV-infected individuals may actually be at lower relative risk of drug-resistant TB. They found that, whereas HIV infection facilitated the rise in numbers of drug-resistant TB The authors developed a mathematical model to explore the effect of HIV on the dynamics of emerging drug-resistant TB. . provide a dynamic look at the relationship between HIV infection and the risk of acquiring et al results. Now, Sergeev developing drug-resistant TB. However, different studies of HIV-infected individuals with TB have yielded conflicting tuberculosis (TB). Some researchers have suggested that HIV-infected populations are more susceptible to can help, but inconsistencies may remain. Such is the case for the epidemiological interactions of HIV and A picture may be worth a thousand words, but a snapshot only gives you part of the story. Comparing snapshots Only Time Will Tell

[1]  S. Rüsch-Gerdes,et al.  High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010 , 2012, Emerging infectious diseases.

[2]  P. V. van Helden,et al.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. , 2011, American journal of respiratory and critical care medicine.

[3]  T. Cohen,et al.  Models to understand the population-level impact of mixed strain M. tuberculosis infections. , 2011, Journal of theoretical biology.

[4]  S. Borrell,et al.  Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  Ellen Brooks-Pollock,et al.  Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. , 2011, The Journal of infectious diseases.

[6]  R. Chaisson,et al.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  L. Ramakrishnan,et al.  Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism , 2011, Cell.

[8]  Reuben Granich,et al.  HIV infection-associated tuberculosis: the epidemiology and the response. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Woojun Park,et al.  Trade-off between antibiotic resistance and biological fitness in Acinetobacter sp. strain DR1. , 2010, Environmental microbiology.

[10]  Sebastian Bonhoeffer,et al.  Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations , 2010, Antimicrobial Agents and Chemotherapy.

[11]  D. van Soolingen,et al.  Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. , 2010, The Lancet. Infectious diseases.

[12]  S. Borrell,et al.  Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  C. Dye,et al.  Slow Elimination of Multidrug-Resistant Tuberculosis , 2009, Science Translational Medicine.

[14]  Andrew R. Francis,et al.  The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.

[15]  S. Lawn,et al.  Epidemiology of HIV-associated tuberculosis , 2009, Current opinion in HIV and AIDS.

[16]  Emily S. Brouwer,et al.  Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review , 2009, PloS one.

[17]  Simon Bergqvist,et al.  Zur Frage der tuberkulsen Primrinfektion bei jungen Erwachsenen , 2009 .

[18]  L. Tanoue Facing Extensively Drug-Resistant Tuberculosis — A Hope and a Challenge , 2009 .

[19]  S. Gagneux Fitness cost of drug resistance in Mycobacterium tuberculosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  T. Cohen,et al.  Latent Coinfection and the Maintenance of Strain Diversity , 2009, Bulletin of mathematical biology.

[21]  Richard D Moore,et al.  Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil , 2008, AIDS.

[22]  S. Swindells,et al.  Extensively drug-resistant tuberculosis. , 2008, The American journal of medicine.

[23]  P. Sonnenberg,et al.  Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines , 2008, AIDS.

[24]  R. Chaisson,et al.  Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing , 2008, Proceedings of the National Academy of Sciences.

[25]  M. Pai,et al.  Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis , 2008, Annals of Internal Medicine.

[26]  A. Galvani,et al.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach , 2008, Epidemiology and Infection.

[27]  R. Frothingham,et al.  The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population. , 2008, The Journal of infectious diseases.

[28]  J. Lazarus,et al.  Tuberculosis–HIV co‐infection: policy and epidemiology in 25 countries in the WHO European region , 2008, HIV medicine.

[29]  P. Nunn,et al.  Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[30]  P. V. van Helden,et al.  Spread of a Low-Fitness Drug-Resistant Mycobacterium tuberculosis Strain in a Setting of High Human Immunodeficiency Virus Prevalence , 2008, Journal of Clinical Microbiology.

[31]  Baojun Song,et al.  Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment. , 2008, Mathematical biosciences and engineering : MBE.

[32]  Christopher Dye,et al.  Eliminating human tuberculosis in the twenty-first century , 2008, Journal of The Royal Society Interface.

[33]  K. Weyer,et al.  Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[34]  S. Basu,et al.  Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study , 2007, The Lancet.

[35]  K. Laserson,et al.  The epidemiology of HIV-associated tuberculosis in rural Cambodia. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[36]  T. Holtz,et al.  HIV infection and multidrug-resistant tuberculosis: the perfect storm. , 2007, The Journal of infectious diseases.

[37]  G. Rutherford,et al.  Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda , 2007, AIDS.

[38]  R. Hayes,et al.  Epidemiology of Tuberculosis in a High HIV Prevalence Population Provided with Enhanced Diagnosis of Symptomatic Disease , 2007, PLoS medicine.

[39]  L. Myer,et al.  Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. , 2007, American journal of respiratory and critical care medicine.

[40]  J. Manson,et al.  Prospective Study of , 2007 .

[41]  A. R. Escombe,et al.  Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. , 2006, The American journal of tropical medicine and hygiene.

[42]  C. Dye,et al.  HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. , 2006, The Journal of infectious diseases.

[43]  K. Freedberg,et al.  CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa: Implications for Prophylaxis and Treatment , 2006, Journal of acquired immune deficiency syndromes.

[44]  C. D. Long,et al.  The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis , 2006, Science.

[45]  L. Myer,et al.  Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  R. Atun,et al.  Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model , 2005, International journal of STD & AIDS.

[47]  M. Feldman,et al.  EVOLUTION OF ANTIBIOTIC RESISTANCE BY HUMAN AND BACTERIAL NICHE CONSTRUCTION , 2005 .

[48]  D. Caugant,et al.  Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. , 2004, FEMS immunology and medical microbiology.

[49]  Ted Cohen,et al.  Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness , 2004, Nature Medicine.

[50]  T. Chou,et al.  Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance , 2004, Nature Medicine.

[51]  R. Hayes,et al.  Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. , 2004, American journal of respiratory and critical care medicine.

[52]  Christopher Dye,et al.  Tuberculosis epidemics driven by HIV: is prevention better than cure? , 2003, AIDS.

[53]  V. Leimane,et al.  Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[54]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[55]  Maja Krčum,et al.  System dynamics simulation modelling of propulsion system (BSVPAM) , 2003 .

[56]  Ted Cohen,et al.  The effect of drug resistance on the fitness of Mycobacterium tuberculosis. , 2003, The Lancet. Infectious diseases.

[57]  Brian G. Williams,et al.  Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis , 2002, Science.

[58]  S. Gillespie,et al.  Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. , 2002, Microbial drug resistance.

[59]  J. Sacarlal,et al.  Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[60]  C. Dye,et al.  Will tuberculosis become resistant to all antibiotics? , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[61]  M G Reynolds,et al.  Compensatory evolution in rifampin-resistant Escherichia coli. , 2000, Genetics.

[62]  P. Sonnenberg,et al.  Tuberculosis treatment failure and drug resistance--same strain or reinfection? , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[63]  A. Reingold,et al.  Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. , 2000, Lancet.

[64]  P. Sonnenberg,et al.  Drug-resistant pulmonary tuberculosis in a cohort of southern African goldminers with a high prevalence of HIV infection. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[65]  G. Ippolito,et al.  Negative Predictors of Survival in HIV-Infected Patients with Culture-Confirmed Pulmonary Tuberculosis , 1999, Infection.

[66]  J. Glynn Resurgence of tuberculosis and the impact of HIV infection. , 1998, British medical bulletin.

[67]  J. Blázquez,et al.  Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection , 1997, The Lancet.

[68]  P E Fine,et al.  The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection , 1997, Epidemiology and Infection.

[69]  R. Wood,et al.  HIV infection is not associated with an increased rate of drug-resistant tuberculosis. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[70]  S. A. Abdool Karim,et al.  A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[71]  F. Plummer,et al.  Recent transmission of tuberculosis in a cohort of HIV‐1‐infected female sex workers in Nairobi, Kenya , 1997, AIDS.

[72]  R. Nogami,et al.  A Five Year Epidemiological Study of Systemic Scleroderma(SSc) in Kumamoto Prefecture from 1988 to 1993. , 1997 .

[73]  T. Frieden,et al.  The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. , 1996, JAMA.

[74]  J. Witte,et al.  Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. , 1996, American journal of epidemiology.

[75]  R. O'brien,et al.  An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993 , 1996, AIDS.

[76]  P. Piot,et al.  Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. , 1995, The New England journal of medicine.

[77]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[78]  A. Kamali,et al.  Two-year HIV-1-associated mortality in a Ugandan rural population , 1994, The Lancet.

[79]  K. McAdam,et al.  The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[80]  R. Hayes,et al.  The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. , 1993, AIDS.

[81]  K. Kerlikowske,et al.  Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. , 1992, The American review of respiratory disease.

[82]  K. D. de Cock,et al.  HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire , 1992, AIDS (London).

[83]  K. McAdam,et al.  Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. , 1992, The American review of respiratory disease.

[84]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[85]  M. Lafontaine,et al.  Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. , 1991, BMJ.

[86]  K. Stýblo The impact of HIV infection on the global epidemiology of tuberculosis. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.

[87]  R. Chaisson,et al.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[88]  R. Luzzati,et al.  NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.

[89]  T. Quinn,et al.  HIV infection in patients with tuberculosis in Kinshasa, Zaire. , 1989, The American review of respiratory disease.

[90]  B. Wallace Can "Stepping Stones" Form Stairways? , 1989, The American Naturalist.

[91]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[92]  S. Radhakrishna,et al.  The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. , 1982, Tubercle.

[93]  G W Comstock,et al.  The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.

[94]  S. Grzybowski,et al.  [The current risk of contracting evolutive tuberculosis, in Saskatchewan, according to the state of previous tuberculin tests and x-ray image]. , 1971, Bulletin of the International Union against Tuberculosis.

[95]  V. Springett Ten-year results during the introduction of chemotherapy for tuberculosis. , 1971, Tubercle.

[96]  J. Myers The natural history of tuberculosis in the human body; forty-five years of observation. , 1965, JAMA.

[97]  G. Várela Comparison of Bacteriological Results with Fresh Faeces and Dried Faeces on Filter Paper in Cases of Diarrhoea. , 1955 .

[98]  C. Lowe Recent Trends in Survival of Patients with Respiratory Tuberculosis , 1954, British journal of preventive & social medicine.

[99]  W. Tattersall The survival of sputum-positive consumptives; a study of 1,192 cases in a county borough between 1914 and 1940. , 1947, Tubercle.

[100]  B. Thompson Survival Rates in Pulmonary Tuberculosis , 1943, British medical journal.

[101]  T. Madsen,et al.  Studies on the epidemiology of tuberculosis in Denmark. , 1942 .

[102]  H. Hilleboe Post-Sanatorium Tuberculosis Survival Rates in Minnesota. , 1941 .

[103]  G. J. Drolet,et al.  Present Trend of Case Fatality Rates in Tuberculosis. , 1938 .